unflappable-isomorphic-deez
Welcome, Guest. Please login or register.

Author Topic: OXiGENE Skyrockets On Trial Results  (Read 319 times)

0 Members and 1 Guest are viewing this topic.

MTnews

  • Hero Member
  • *****
  • Posts: 734
  • Karma: 1
    • View Profile
OXiGENE Skyrockets On Trial Results
« on: March 12, 2014, 07:10:14 PM »
Daily Market Commentary for March 12, 2014

OXiGENE, Inc. (OXGN-Nasdaq) announced late Tuesday, positive results from a randomized Phase 2 clinical trial evaluating Avastin(R) (bevacizumab) with or without ZYBRESTAT(R) (fosbretabulin; CA4P) to treat patients with recurrent ovarian cancer.

Read More at:http://www.millennium-traders.com/news/newscommentary.aspx


Thanks for reading
Millennium-Traders.Com
http://www.millennium-traders.com

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
2389 Views
Last post February 21, 2007, 02:57:35 PM
by The Web Team
0 Replies
1147 Views
Last post October 16, 2007, 07:00:56 AM
by The Web Team
1 Replies
1215 Views
Last post November 29, 2007, 02:02:45 PM
by Deez
0 Replies
1344 Views
Last post January 14, 2008, 09:14:48 AM
by The Web Team
0 Replies
835 Views
Last post February 26, 2008, 09:00:55 AM
by The Web Team
0 Replies
889 Views
Last post April 14, 2008, 06:00:35 AM
by The Web Team
0 Replies
887 Views
Last post July 08, 2008, 03:08:38 PM
by The Web Team
0 Replies
889 Views
Last post July 31, 2008, 06:12:07 AM
by The Web Team
0 Replies
963 Views
Last post August 20, 2008, 05:05:27 AM
by The Web Team
0 Replies
593 Views
Last post May 06, 2009, 04:04:24 PM
by MTnews